echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > medRxiv: Omicron's severe severity and mortality have dropped significantly compared to Delta, with a 91% lower risk of death

    medRxiv: Omicron's severe severity and mortality have dropped significantly compared to Delta, with a 91% lower risk of death

    • Last Update: 2022-01-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Researchers at the University of California, Berkeley, Kaiser Permanente Hospital of Southern California, and the U.
    S.
    Centers for Disease Control and Prevention published a paper in preprint today, analyzing about 52,000 people infected with the Omicron mutant and about 17,000 people infected with the Delta mutant.
    Compared with Delta, people infected with Omicron were 50% less likely to be hospitalized, 75% less likely to be admitted to the ICU, and 91% less likely to die
    .

    52,000 infected with Omicron mutant 52,000 infected with Omicron mutant 17,000 infected with Delta mutant 17,000 infected with Delta mutant were half as likely to be hospitalized, 75% less likely to be admitted to the ICU, and less likely to die 91% less likely to be hospitalized, 75% less likely to be admitted to the ICU, and 91% less likely to die

    The median length of hospital stay for people with Omicron was 1.
    5 days, compared to a Delta of 5 days, and 90% of people with Omicron were discharged in 3 days or less
    .


    None of the 52,000 people infected with the Omicron mutant ended up on a ventilator , compared with 11 of the 17,000 people infected with the Delta mutant


    The median length of hospital stay for people with Omicron was 1.


    Attributes of cases with SGTF (Omicron) and non-SGTF (Delta [B.
    1.
    617.
    2]) samples detected

    CDC Director Rochelle Walensky said the study controlled for important key parameters such as age, gender, previous journals of Covid-19 infection, vaccinations and comorbidities
    .


    The results of this study show that Omicron is inherently less severe than Delta


    Rochelle Walensky also cautioned that while the study showed a significant drop in the risk of hospitalization, severe illness and death after Omicron infection, it should not let down our guard now, because Omicron is so contagious that the current U.
    S.
    health care system and health care workers Overwhelmed
    .

     

    About 1 million people in the U.
    S.
    are currently infected every day, most of them Omicron, 150,000 people are hospitalized with the new crown every day, and more than 1,600 people die every day from it
    .

    Anthony Fauci, President Biden's chief medical adviser, said: " Omicron, with its powerful and unprecedented transmission efficiency, will eventually infect almost everyone [in the United States]
    .


    He also said that when the United States emerges from the current wave of infections, it will transition to a state of coexistence with the new coronavirus in the future, and the new crown vaccine can help most people avoid developing severe disease and provide effective treatment for those most vulnerable


    With its powerful and unprecedented transmission efficiency, Omicron will eventually infect almost all (US) people In the future transition to coexistence with the new coronavirus, the new crown vaccine can help most people avoid developing severe disease and provide effective treatment for those most vulnerable

    Original source:

    Original source:

    Joseph A.


    Clinical outcomes among patients infected with Omicron (B.
    1.
    1.
    529) SARS-CoV-2 variant in southern California
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.